Austrian Myeloid Registry (aMYELOIDr)

Arbeitsgemeinschaft medikamentoese Tumortherapie

Status: Enrolling

Conditions: Myeloid Diseases

Treatments: Other: Non-interventional

Study type: Observational

Funder types: Other

Identifiers

NCT04438889

AGMT_aMYELOIDr

Details and patient eligibility

About

The Austrian Myeloid Registry (aMYELOIDr) is a non-interventional study. It collects data from patients with the myeloid diseases, primarily myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).The aMYELOIDr is multi-center database collecting data at various sites in Austria and potentially also at other centers in other countries in future. The registry has an electronic case report form (eCRF), where all data is entered by clinical trial personnel and/or physicians. It is set up to collect real-world experience in the management of patients with these diseases in Austria.

Enrollment: 3,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age >17 years
• Diagnosis of myeloid disease according to WHO 2016
• Signed patient informed consent (IC)

Exclusion criteria

• Patient is unable or unwilling to sign IC

Trial design

3,000 participants in 4 patient groups

AML

Description:

Patients with WHO 2016 diagnosis of AML

Treatment:

Other: Non-interventional

MDS

Description:

Patients with WHO 2016 diagnosis of MDS

Treatment:

Other: Non-interventional

CMML

Description:

Patients with WHO 2016 diagnosis of CMML

Treatment:

Other: Non-interventional

PMF

Description:

Patients with WHO 2016 diagnosis of PMF

Treatment:

Other: Non-interventional